Norris Medicines Limited (BOM:524414)

India · Delayed Price · Currency is INR

13.72

+0.07 (0.51%)

At close: Sep 7, 2026

Market Cap	137.21M -18.9%
Revenue (ttm)	76.00M +16.0%
Net Income	-3.67M
EPS	-0.37
Shares Out	10.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81
Open	13.50
Previous Close	13.65
Day's Range	13.50 - 13.72
52-Week Range	12.00 - 19.63
Beta	-0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp... [Read more]

Industry Pharmaceutical Preparations

Founded 1990

Employees 33

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524414

Full Company Profile

Financial Performance

In fiscal year 2026, Norris Medicines's revenue was 81.32 million, an increase of 39.72% compared to the previous year's 58.20 million. Losses were -2.81 million, -77.33% less than in 2025.

Financial Statements